SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-19-000442
Filing Date
2019-11-13
Accepted
2019-11-13 17:15:07
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q klfe093019form10q.htm 10-Q 703016
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12288
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11837
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5076
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5152
  Complete submission text file 0001607062-19-000442.txt   3094188

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE klfe-20190930.xml EX-101.INS 441455
7 XBRL SCHEMA FILE klfe-20190930.xsd EX-101.SCH 41121
8 XBRL CALCULATION FILE klfe-20190930_cal.xml EX-101.CAL 50423
9 XBRL DEFINITION FILE klfe-20190930_def.xml EX-101.DEF 121258
10 XBRL LABEL FILE klfe-20190930_lab.xml EX-101.LAB 219047
11 XBRL PRESENTATION FILE klfe-20190930_pre.xml EX-101.PRE 203050
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 858-883-2642
Kannalife Inc (Filer) CIK: 0001615999 (see all company filings)

IRS No.: 462645343 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55657 | Film No.: 191215173
SIC: 2834 Pharmaceutical Preparations